Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Insys Theraptcs Cmn (INSY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 736,243
  • Shares Outstanding, K 72,110
  • Annual Sales, $ 242,280 K
  • Annual Income, $ 7,590 K
  • 36-Month Beta 0.70
  • Price/Sales 3.10
  • Price/Cash Flow 39.42
  • Price/Book 2.77

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.86 +3.55%
on 04/06/17
11.69 -12.66%
on 03/23/17
+0.24 (+2.41%)
since 03/21/17
3-Month
9.30 +9.78%
on 02/14/17
13.69 -25.42%
on 02/23/17
+0.21 (+2.10%)
since 01/20/17
52-Week
8.70 +17.36%
on 12/08/16
19.96 -48.85%
on 08/10/16
-5.51 (-35.05%)
since 04/21/16

Most Recent Stories

More News
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in INSYS Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - INSY

NEW YORK, NY / ACCESSWIRE / April 14, 2017 / Pomerantz LLP announces that a class action lawsuit has been filed against INSYS Therapeutics, Inc. ("Insys" or the "Company") (NYSE: INSY) and certain of its...

INSY : 10.21 (-2.02%)
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Has Filed in U.S. District Court to Recover Losses Suffered by Investors in INSYS Therapeutics, Inc.

The following statement is being issued by Levi & Korsinsky, LLP:

INSY : 10.21 (-2.02%)
The Klein Law Firm Announces the Filing of a Class Action on Behalf of INSYS Therapeutics, Inc. Shareholders and a Lead Plaintiff Deadline of May 16, 2017

NEW YORK, NY / ACCESSWIRE / April 10, 2017 / The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of INSYS Therapeutics, Inc. (NASDAQ: INSY) who purchased...

INSY : 10.21 (-2.02%)
CBD Market Gains Attention

The CBD market holds a significant share of the entire legal cannabis market. Cannabidiol (CBD) is the part of the plant used for medical purposes and the market is projected to significantly increase...

KSHB : 2.5300 (-3.07%)
CBDS : 5.0300 (-2.14%)
ESSI : 2.2900 (-15.19%)
INSY : 10.21 (-2.02%)
CIIX : 1.0920 (-4.21%)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in INSYS Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - INSY

NEW YORK, NY / ACCESSWIRE / April 7, 2017 / Pomerantz LLP announces that a class action lawsuit has been filed against INSYS Therapeutics, Inc. ("Insys" or the "Company") (NASDAQ: INSY) and certain of...

INSY : 10.21 (-2.02%)
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Insys Therapeutics, Inc. - INSY

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Insys Therapeutics, Inc. securities (NASDAQ:INSY) from February 23, 2016 through...

INSY : 10.21 (-2.02%)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against INSYS Therapeutics, Inc. (INSY) & Lead Plaintiff Deadline: May 16, 2017

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against INSYS Therapeutics, Inc. ("INSYS" or the "Company") (NASDAQ:INSY) and certain...

INSY : 10.21 (-2.02%)
Marijuana Market Offers Variety of Investment Options and Consistent, Long-Lasting Growth Potential

NetworkNewsWire Editorial Coverage

IIPR : 18.44 (+2.39%)
AXIM : 11.8100 (-5.52%)
SING : 0.0550 (-4.18%)
INSY : 10.21 (-2.02%)
MSRT : 0.7350 (-7.55%)
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders it Has Filed to Recover Losses Suffered by Investors in INSYS Therapeutics, Inc. and Set a Lead Plaintiff Deadline of May 16, 2017 -- INSY

NEW YORK, NY / ACCESSWIRE / April 4, 2017 / The following statement is being issued by Levi & Korsinsky, LLP:

INSY : 10.21 (-2.02%)
Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Insys Therapeutics, Inc. Investors and Encourages Investors to Contact the Firm

Glancy Prongay & Murray LLP ("GPM") announces that a class action lawsuit has been filed on behalf of investors who purchased Insys Therapeutics, Inc. ("Insys" or the "Company") (NASDAQ:...

INSY : 10.21 (-2.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More

Business Summary

Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. It is engaged in the development and commercialization of pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's cancer-supportive care and...

See More

Support & Resistance

2nd Resistance Point 10.70
1st Resistance Point 10.46
Last Price 10.21
1st Support Level 10.06
2nd Support Level 9.90

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.